Resistance genes to murine leukemia in the I immune response gene region of the H-2 complex by unknown
Brief Definitive Report 
RESISTANCE  GENES  TO  MURINE 
LEUKEMIA  IN  THE  I  IMMUNE  RESPONSE  GENE 
REGION  OF  THE H-2  COMPLEX 
B~ PETER  LONAI  AND NECHAMA  HARAN-GHERA 
(From the Department of Chemical Immunology,  The Weizmann Institute of Science, Rehovot, 
Israel) 
It is generally believed that one of the elements of host resistance to leukemia 
is the immune response.  Immune responsiveness to many antigens is  under 
genetic control, regulated by Ir  genes linked to the major histocompatibility 
complex  (1).  Ir  gene  regulation  in  the  mouse  is  most  likely based  on  two 
complementing Ir genes localized within the H-2 complex (2). 
Involvement of the H-2  complex  in  resistance  to  leukemogenesis is  well 
established (3). An H-2-1inked resistance gene against leukemogenesis by Gross 
leukemia virus, Rgv-1,  was described and localized by Lilly (4).  The genetic 
position of Rgv-1  is to the left of the right border of the H-2 complex (H-2D), 
either within H-2 or to the left of it (4). Evidence for involvement of a locus (X-l) 
with similar localization to Rgv-1, in immune responsiveness to transplantable, 
radiation-induced leukemias was presented by Sato et al.  (5).  These findings 
suggest that H-2-1inked Ir genes are involved in the host's immune response to 
leukemogenesis. More recently Chesebro et al. have described a resistance gene 
for Friend virus leukemogenesis, RFV-1 and localized it to H-2D (6). It has been 
shown that the H-2  complex contains a  large number of loci,  which control 
several different immunological functions, such as complement components and 
target antigens for alloimmune killer cells. Thus the distinctly localized Ir genes 
are  only  a  part  of the H-2-1inked  loci.  In  light  of these  data,  the  genetic 
localization of loci Rgv-1 and X-1 is not entirely sufficient for their identification 
with Ir genes, because of the limited genetic material investigated at the time of 
their description (4, 5). 
In this report we present evidence for the localization of a resistance gene to 
virus-induced murine leukemia within the left part of the I region, and suggest 
that it is in complementation with an additional gene also situated within the 
H-2  complex. This genetic localization is consistent with that of the comple- 
menting Ir genes (2). 
Materials and Methods 
Animals.  All mouse strains used in this study were bred in our Animal House. The breeding 
nuclei were either gifts from Doctors D. C. Shreffler (Washington University, St. Louis, Mo.), H. 
O.  McDevitt (Stanford University, Stanford,  Calif.),  F.  Lilly (Albert Einstein Medical Center, 
Bronx, N. Y.), or purchased from The Jackson Laboratories (Bar Harbor, Maine). 
Virus Preparation.  A-RadLV,  a  line highly oncogenic in young adult C57BL/6 mice,  origi- 
nated in the bone marrow of irradiated mice, and is passaged in vivo as a  cell-free supernate of 
homogenates from leukemic thymuses, as described previously (7). 
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Treatment and Diagnosis.  0.02 ml of a  20% (on the basis of the weight of the thymus tissue) 
cell-flee supernate was injected into the thymus of young adult mice. Atter approximately 2 mo 
the animals were inspected weekly and the sick mice were isolated. The animals were sacrificed in 
a terminal state and autopsied, and when necessary histological examination was performed. The 
genetic evaluation of the results was based on works by Shreffier and David (8), Klein (9), David 
(1O), and Murphy et al.  (11). 
Results and Discussion 
For the first experiment mouse strains were selected on the basis of their H-2 
and Fv-1  type. Where the availability of congenic strains permitted, the same 
independent H-2  haplotype was tested on at least two different backgrounds. 
Two conclusions could be drawn from this experiment (Table I). First it became 
apparent that the Fv-1 b type congeneic series on the B6,  B10, BALB, and A 
backgrounds are sensitive, while the Fv-1 n type on the C3H and DBA mice are 
resistant to leukemogenesis by a variant of the radiation leukemia virus (A- 
RadLV). This observation is in agreement with the known effect of the Fv-1 
resistance locus (3), and with the in vitro studies of Decl~ve et al. which suggest 
that RadLV is an Fv-1  B-tropic virus (12). The second conclusion was that the 
leukemogenic effect of A-RadLV depends on the H-2 haplotype in Fv-1 ~ mouse 
strains. It can be seen from Table I that haplotypes r, b, k, and d  (in this order) 
are sensitive, f is probably intermediate, while s is resistant to leukemogenesis 
by A-RadLV. 
In the subsequent experiments strains carrying chromosomal recombinations 
within the  H-2 complex were investigated. These strains were selected either for 
recombination between the resistant s and the sensitive k and d haplotypes, or 
for recombination between two sensitive haplotypes like k and b, d and b, or b 
and a. The first group could give information  on the localization of a resistance 
locus within the H-2  complex on the basis  of the suggested position of the 
recombination event in these strains. The second group was planned to detect 
whether some of these sensitive genotypes would complement for resistance. 
Additionally haplotypes  yl and y2 were tested, and were found to be sensitive to 
leukemogenesis with A-RadLV, suggesting that q may be an additional sensi- 
tive H-2  haplotype. The two main groups (t2, t3,  tl, an1  and h4, g, a,  i, i5, 
respectively) however gave more detailed information which will be analyzed 
separately in Tables III and IV. 
It can be seen in Tables II and III, that haplotypes tl and an1  (strains A.TL 
and A.TFR1) which contain elements of the resistant s and of the sensitive k, a, 
or f haplotypes were highly sensitive, while t2 and t3 which are similar to these 
in  origin,  but  differ in  the position  of the recombination, were resistant to 
leukemogenesis by A-RadLV.  These data  suggest that  a  resistance gene is 
localized between H-2K and subregion I-E in the left part of the I region of the 
H-2 complex. The left limit of this localization is indicated by the sensitivity of 
strains A.TL and A.TFR1 which carry the H-2K" allele of the resistant A.SW 
strain and have sensitive k alleles in the I region. The right limit is indicated by 
resistance in the B10.HTT strain which have resistant s alleles in H-2K and in 
subregions I-A, I-B, and I-J, and sensitive k and d alleles in the rest of its H-2 
complex. Additionally, Tla types a, c, and b appear in this group, both in the 
resistant and in the sensitive strains, suggesting that this locus is not involved 
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TASLE  I 
Leukemogenic Effect of  A-RadL V-Independent 1-1-2 Haplotypes: Effect of the H-2 and Fv-1 
Loci 
$'-1  1"1-2  Leukemia/total  Leukemia  Latency  ±  SE  First-last ease 
%  days 
C57BL/6J  b  b  20/20  100  85  ±  16  63-127 
C57BL/10Sn  b  b  45/45  100  87 ±  37  73-198 
BALB.B10/Li  b  b  15/24  63  128  ±  56  72-305 
B10.D2/nSn  b  d  10/13  77  105  ±  32  74-169 
A.CA/Sn  b  f  6/14  43  107  ±  28  74-137 
B6-H-2k/Boy  b  k  10/14  71  121  ±  73  63-317 
B10.BR/Sg  b  k  7/7  100  124 ±  59  85-211 
BALB.C3H/Li  b  k  13/16  81  122 ±  77  72-298 
B10.RIII/J  b  r  14/15  93  '  69  ±  3  66-72 
B10.S/Sg  b  s  2/19  11  122  96-147 
A.SW/Sn  b  s  1/17  6  127  - 
C3H.SW/Sn  n  b  1/18  6  338  - 
DBA/2J  n  d  0/13  0  -  - 
C3H/DiSn  n  k  1/19  5  140  - 
C3H/eBJ  n  k  1/20  5  159  - 
TABLE  II 
Leukemogenic  Effect  of A-RadL  V  Recombinant  1t-2  Haplotypes 
H.2  Origin*  Leukemia/total  Leukemia  Latency  ±  SE  First-last case 
%  days 
B10.A/Sg  a  k/d  33134  97  87  ±  24  68-184 
A.TFRI/Sf  an1  tl/f  20/21  95  87 ±  16  63-127 
B10.HTG/Li  g  d/b  13/19  68  99  _+  19  74-127 
B10.A(4R)/Sg  h4  a/b  21/21  100  93  ±  18  74-147 
HTI/Go  i  b/a  14116  88  79  ±  19  74-120 
B10.A(SR)/Sg  i5  b/a  2/18  11  94  85-102 
A.TL/Sf  tl  b/al  19/22  86  111  ±  18  85-137 
A.TH/Sf  t2  b/a  2/17  12  160  127-192 
B10.H2~F/Pb  t3  s/t1  3/23  13  215  127-211 
B10.AQR/4NKlj  yl  q/a  16117  94  89  ±  32  55-156 
B10.T(6R)/Sg  .),2  q/a  9/15  60  97 ±  26  63-147 
* The parental  haplotypes  between  which the recombination  occurred. 
conclude from these data  that  in mouse strains  carrying the permissive Fv-1 
allele, viral leukemogenesis is most likely under the control of a locus within the 
left part  of the I  region.  We propose Rrv-1  (resistance to radiation  leukemia 
virus) as the preliminary  designation  for this locus.  It is noteworthy that the 
localization of Rrv°l  is very similar to that of most known Ir genes (1, 8). 
Another  interesting  observation was made in recombinant  strains  between 
sensitive haplotypes. Five such recombinant haplotypes were tested a, g, h4, i, 
and  i5.  It can be seen from Tables II  and  IV that  one of these five strains, 
B10.A(5R), despite being the descendent of the sensitive b and a haplotypes, was 
resistant to A-RadLV. The most plausible explanation for phenotypic resistance 
in  a  genotype  which  derives  from  the  recombination  of loci  from  sensitive 
origins,  is  the  complementation  of two  resistance  genes.  In  line  with  this 
explanation the data analyzed in Table IV, suggest that in the origin ofrecombi- LONAI  AND  HARAN-GHERA  BRIEF  DEFINITIVE  REPORT  1167 
TASLE IH 
Localization of a Resistance Locus, Rrv-1, for Leukemogenesis  by A-RadL  V 
14-2  Origin  H-2K  I-A  I-B  1-J  I-E  l-C  S  H-2G  H-2D  Tla  Leukemia 
C57BL/10J  b  -  b  b  b  b 
B10.BR/Sg  k  -  h  h  k  k 
B10.D2/nSn  d  -  d  d  d  d 
B10.S/Sg  s  -  s  s  s  s 
A.TH/Bf  t2  s/a  s  s  s  s 
B10.HTT/Ph  t3  stl  s  s  s  s 
( 








b  b  b  b  b  b  100 
h  h  h  h  k  a  100 
d  d  d  d  d  c  77 
s  s  s  s  s  b  11 
s  s  s  [  s  L  d  a  12 
k  k  h  k  d  c  13 
k  k  k  h  d  c  86 
h  k  h  j  f  f  a  95 
TABLE IV 
Complementation of  Resistance Genes for Leukemogenesis  by A-RadL  V within the H-2 
Complex 
H-2  Origin  H-2K  I-A  I-B  l-J  I-E  I-C  S  H-2G  H-2D  Tla  Leukemia 
% 
B10.A(4R)/Sg  h4  a/b  h  h  b  b  b  b  b  b  b  b  100 
B10.HTG/Li  S  d/b  d  d  d  d  d  d  d  b  b  68 
B10.A/Sg  a  h/d  k  k  k  k  k  d  d  d  d  a  97 
HTI/Go  i  b/a  b  b  b  b  b  b  b  !  d  a  88 
B10.A(5R)/Sg  /5  b/a  b  I  b  b  ~i  h  h  d  d  !  d  d  a  1  11 
nant/5,  the H-2  ° parent donated a  resistance gene localized in the H-2K-I-E 
interval, while the H-2  a parent donated a second resistance locus localized to the 
right of it. It is reasonable to assume that the left locus should be identical with 
the above described Rrv-1. The localization of the second locus is indicated by 
the sensitivity of another b/a recombinant, HTI, and suggests that this locus is 
situated to the right of H-2D and to the left ofRrv-1. The complementation of 
two loci inside the H-2 complex is a characteristic of  Ir genes. In one of the best 
known examples,  for the immune responsiveness  to the synthetic antigen L- 
Glu,L-Lys,L-Phe,  Dorf et al. (2) have denoted the two loci as a and ~. There is a 
striking similarity between their genetic data on the localization of  complement- 
ing Ir  genes  for  the  regulation  of an  antibody  response,  and  ours  on  the 
regulation of sensitivity to leukemogenesis.  The data presented here strongly 
support  the  view  that  one  of the  functions  of the  major  histocompatibility 
complex in leukemia may be analogous to that of  Ir genes. 
It is of interest to note that the resistant vs. sensitive H-2 haplotypes for A- 
RadLV leukemia were found to be different from those for the very similar Gross 
virus leukemia (3, 4). This may indicate that there is a degree of polymorphism 
in the H-2-1inked regulation of sensitivity to murine leukemia. Therefore, it will 
be of special interest to study the effect of the H-2 complex on leukemogenesis by 
the closely related original RadLV described by Kaplan (13). 
Summary 
A  resistance locus to leukemogenesis in mice by A-RadLV (a variant of the 1168  LONAI  AND  HARAN-GHERA  BRIEF  DEFINITIVE  REPORT 
radiation leukemia virus) is described.  This locus, Rrv-1, was mapped to subre- 
gions I-A, I-B, and I-J of the H-2 complex. It is suggested that Rrv-1 may be in 
complementation with a second locus to the right of  it, betweenRrv-1 andH-2D. 
This  localization and the complementation of the two loci for resistance  are 
characteristics similar to Ir genes, and indicate a possible relationship between 
the genetic regulation of  immune responsiveness and susceptibility to leukemia. 
Received for publication 27 April 1977. 
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